Natural product-derived antiviral therapy for HIV virus: Triptolide, isolated from herb Thunder God Vine, increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 19/March/2017, 8.24 pm

MiRNA-based Life-span extension therapy: MiR-761 may increase lifespan by suppressing mTOR pathway, 19/March/2016, 7.49 am
March 19, 2017
Natural product-based Lifespan extension therapy: Polydatin (PD), isolated from the root and rhizome of herb Polygonum cuspidatum, activates autophagy and extends lifespan via up regulation of ATG5, 19/March/2017, 9.45 am
March 19, 2017
Show all

What we say:

Dr L Boominathan PhD, Director-Price 100cum-chief Scientist of GBMD, reports that: Natural product-derived antiviral therapy for HIV virus: Triptolide, isolated from herb Thunder God Vine, increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene

[easy_payment currency=”USD”]


From Significance of the study to Public health relevance:

Given that: (1) more than 37 million people worldwide are living with HIV/AIDS; (2) there is no effective vaccine available for HIV/AIDS; (3) HIV/AIDS tops the list of incurable diseases in humans; (4) the life-long painful drug treatment is required to treat HIV/AIDS and its associated opportunistic infections; (5) the global economic cost spent for HIV treatment is enormous, there is an urgent need to find: (i) a way to restore CD4 T-cells that were lost in HIV/AIDS; (ii) a cheaper alternative to the existing expensive antiviral drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, HIV-1/AIDS.


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, a natural product-based antiviral therapy against RNA viruses such as HIV-1.

Triptolide, by increasing the expression of its target gene, it may increase the expression of Heme oxygenase-2 (HO-2) (Figure 1). Thereby, it may: (1) bind and block the myristate moiety of HIV-1 Gag protein; (2) disrupt HIV-1 budding; (3) restrict HIV-1 infectivity, replication and production; (4) promote clearance of HIV-1 and MLV virions; and (5) strengthen antiviral immunity against RNA viruses.

Triptolide inhibits HIV1 propagation

Figure 1 Mechanistic insights into how Triptolide functions as an anti-HIV agent. Triptolide inhibits HIV-1 budding and production via up-regulation of HO-2

Thus, pharmacological formulations encompassing Triptolide or its analogs either alone or in combination with other drugs” may be used to inhibit HIV-1 production.

[easy_payment currency=”USD”]


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does Triptolide increase the expression of Heme oxygenase-2 (HO-2)?

Amount: $100#

For payment and purchase details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com/

Citation: Boominathan, L., Natural product-derived antiviral therapy for HIV virus: Triptolide, isolated from herb Thunder God Vine, increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 19/March/2017, 8.24 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at admin@genomediscovery.org

Comments are closed.